TopiVert Begins Phase 1 Study of Oral TOP1288 as Colitis Treatment
News
The first participant has been dosed in a Phase 1 American study evaluating TopiVert Pharma‘s oral version of TOP1288 as a treatment for ulcerative colitis (UC). The study will assess TOP1288’s ... Read more